PitNETs are associated with conditions linked to alternative splicing, which may activate oncogenic pathways, and express the neurotrophin receptor tropomyosin receptor kinase A (TrkA), which exhibits oncogenic alternative TrkAIII splicing in other neuroendocrine tumors. Here, NTRK1 is linked to neuroendocrine neoplasm.